Verrica Pharmaceuticals (VRCA) Depreciation and Depletion (2018 - 2026)
Verrica Pharmaceuticals has reported Depreciation and Depletion over the past 6 years, most recently at $17000.0 for Q1 2026.
- For Q1 2026, Depreciation and Depletion fell 67.31% year-over-year to $17000.0; the TTM value through Mar 2026 reached $116807.0, down 60.27%, while the annual FY2025 figure was $133000.0, 61.11% down from the prior year.
- Depreciation and Depletion for Q1 2026 was $17000.0 at Verrica Pharmaceuticals, down from $33000.0 in the prior quarter.
- Over five years, Depreciation and Depletion peaked at $177000.0 in Q4 2022 and troughed at $17000.0 in Q1 2026.
- A 5-year average of $86576.9 and a median of $100000.0 in 2023 define the central range for Depreciation and Depletion.
- Biggest five-year swings in Depreciation and Depletion: surged 790.91% in 2022 and later crashed 78.19% in 2025.
- Year by year, Depreciation and Depletion stood at $177000.0 in 2022, then decreased by 26.55% to $130000.0 in 2023, then tumbled by 67.69% to $42000.0 in 2024, then fell by 21.43% to $33000.0 in 2025, then crashed by 48.48% to $17000.0 in 2026.
- Business Quant data shows Depreciation and Depletion for VRCA at $17000.0 in Q1 2026, $33000.0 in Q4 2025, and $21807.0 in Q3 2025.